FDA Inspection 1235782 — Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
The FDA completed an inspection of Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd. on Mar 22, 2024 in Tianjin. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 22, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tianjin (China)